Nanjing King-Friend successfully accessed authorization of 6 patents on March 29, 2024, including 5 utility model patents and 1 invention patent.
These patents are “A Kind of High Rack Warehouse Temperature Controlling System ”, “Syrine Blister Boxing Machine”, “Blow Molding Mold of Injection Plastic Package Material”, “Tightening Auxiliary Device of Injection Labelling Machine”, “Injection Labelling Machine” and “A Kind of Membrane Filtration Method for Testing Microbial Enumeration for Intermediate of Daptomycin for Injection ”.
Nanjing King-Friend has obtained 6 licensing patents so far this year, surging by 500% compared with same period last year.
Nanjing King-Friend will continue to pursue innovative R&D and thoroughly push forward high-quality development, keeping sense of mission and responsibility for invigorating China through science in heart and remaining true to our original aspiration for providing Chinese with high-quality medicines.
